Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -10.00 (-3.67%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £78.94m
MPAC Live PriceLast checked at - London Stock Exchange

Intraday Mpac Group Plc Share Chart

Full Year Trading update

16 Jan 2025 07:00

RNS Number : 4994T
Mpac Group PLC
16 January 2025
 

16 January 2025

AIM: MPAC

 

Mpac Group plc

(''Mpac'', "Company" or "Group")

 

Full Year Trading update

 

FY24 trading performance in line with market expectations, a healthy opening order book for 2025 and good initial progress made on integrating H2 24 acquisitions

 

 

Mpac Group plc, a global leader in high-speed packaging and automation solutions, today announces a trading update (unaudited) for the year ended 31 December 2024 ("FY24").

 

The Board is pleased with the Group's FY24 performance and expects that it will report underlying profit before tax in line with market expectations of £10.5m (FY23: £7.1m). As anticipated, profit before tax in H2 24 was substantially above H1 24, aided by improving project margins and operational efficiencies.

 

The Group successfully executed the acquisitions of BCA Automation and CSi Palletising in H2 24 (the "Acquisitions"). The Acquisitions have continued to perform in line with the Board's expectations. The integration is progressing well and according to plan.

 

After the completion of the Acquisitions, the Group closes FY24 with net debt of £37.0m (FY23: net cash £2.1m) and a reduction in working capital to £7.0m (FY23: £13.2m), which includes circa £8.0m of invoiced receivables, due in 2024, most of which has been received in early January 2025. The Group remains on track to bring net debt down to less than 1 times EBITDA by the end of 2025.

 

Quote activity and the prospect pipeline within the growth sectors in which Mpac operates of Healthcare and Food and Beverage continues to be strong and following the Acquisitions, the Group ended FY24 with an increased value of the closing order book at c.£111.0m (FY23: £72.5m) providing good coverage over 2025 forecast revenue. 

 

With an increasingly diverse prospect pipeline and order book and good quote activity, as well as a stronger offering through combined product lines from our existing and acquired businesses, the Group is well placed to deliver on market expectations for the current financial year and beyond. The Board remains confident that the Group will continue progressing its long-term growth strategy.

 

Adam Holland, Chief Executive, commented:

 

We are pleased with full year 2024 financial performance, which is in line with market expectations. 2024 has proved to be a transformational year for the Group, with the acquisitions of CSi, BCA and Siga Vision providing the platform for a step change in scale and profitability, accelerating our progress towards our strategic objectives. The acquisitions materially diversify the Group's portfolio enabling the Group to provide a fuller line offering, as well as access to new customer relationships providing a platform for continued robust organic growth.

 

We would like to thank shareholders for their support of the acquisition of CSi and their ongoing support as we head into 2025. We anticipate reporting for 2024 record levels of revenue, with underlying profit before tax breaking through the £10m mark for the first time. We start 2025 with a larger and more diverse order book from our resilient end markets providing a high level of coverage over forecast revenue, supporting delivery of our expectations for further growth in the year ahead.''

 

The Group's full year results for the year ended 31 December 2024 are expected to be announced in the week commencing 28 April 2025, allowing for the additional time required to complete the first audit of the enlarged Group following the recent significant acquisitions.

 

 

For further information, please contact:

Mpac Group plc

Adam Holland, Chief Executive

Will Wilkins, Chief Financial Officer

Tel: +44(0)24 7642 1100

Shore Capital (Nominated Adviser & Broker)

Advisory

Patrick Castle

Sophie Collins

Broking

Henry Willcocks

 

 

Tel: +44(0)20 7408 4050

 

Panmure Liberum (Joint Broker)

Edward Mansfield

Will King

Anake Singh

 

Hudson Sandler (Financial PR)

Nick Lyon

Nick Moore

Francesca Rosser

Tel: +44 (0) 20 3100 2000

 

 

 

 

Tel: +44 (0) 20 7796 4133

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUCCGUPAGMA
Date   Source Headline
15th May 20267:00 amRNSAvailability of 2025 Annual Report & Notice of AGM
24th Apr 20262:00 pmRNSAIM Rule 17 Disclosure
21st Apr 20267:01 amRNSChief Financial Officer Succession
21st Apr 20267:00 amRNSFull Year Results
24th Mar 20267:00 amRNSNotice of Results and Investor Presentation
18th Feb 20264:52 pmRNSChange of Registered Office
2nd Feb 20263:19 pmRNSDirector/PDMR Shareholding
15th Jan 20267:00 amRNSAppointment of Senior Independent Director
15th Jan 20267:00 amRNSFull Year trading update and notice of results
31st Oct 202511:54 amRNSHolding(s) in Company
24th Oct 202510:55 amRNSDirector/PDMR Shareholding
2nd Oct 20254:10 pmRNSDirector/PDMR Shareholding
30th Sep 202512:38 pmRNSHolding(s) in Company
23rd Sep 20257:05 amRNSDirectorate Changes
23rd Sep 20257:00 amRNSHalf Year Results
10th Sep 20252:14 pmRNSNotice of Results and Investor Presentation
31st Jul 20252:26 pmRNSDirectorate Change
8th Jul 202511:39 amRNSHolding(s) in Company
4th Jul 20255:55 pmRNSDirector/PDMR Shareholding
1st Jul 20258:00 amRNS-REquity Development Investor Presentation
1st Jul 20257:00 amRNSDefined Benefit Pension Scheme Update
1st Jul 20257:00 amRNSTrading Update
12th Jun 20255:40 pmRNSResult of AGM
6th Jun 20254:03 pmRNSHolding(s) in Company
23rd May 202511:38 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSNotice of AGM
8th May 20254:55 pmRNSDirector/PDMR Shareholding
2nd May 20251:03 pmRNSDirector/PDMR Dealing
29th Apr 20257:00 amRNSFinal Results
7th Apr 20257:00 amRNS-REquity Development Investor Presentation
24th Mar 202510:39 amRNSNotice of Results
25th Feb 20257:00 amRNS-RPension Scheme Valuation Update
23rd Jan 20258:32 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSFull Year Trading update
7th Jan 20253:03 pmRNSHolding(s) in Company
29th Nov 20242:55 pmRNSCompletion of the Acquisition of CSi Palletising
5th Nov 202412:55 pmRNSStandard form for notification of major holdings
5th Nov 20249:39 amRNSStandard form for notification of major holdings
4th Nov 20248:57 amRNSStandard form for notification of major holdings
23rd Oct 20242:55 pmRNSStandard form for notification of major holdings
23rd Oct 202411:25 amRNSStandard form for notification of major holdings
18th Oct 20249:54 amRNSResult of General Meeting
8th Oct 20247:00 amRNSResult of Retail Offer
1st Oct 202412:05 pmRNSResult of Placing
1st Oct 20248:00 amRNSProposed Retail Offer to raise up to £1 million
1st Oct 20247:20 amRNSProposed Placing to raise £29 million
1st Oct 20247:00 amRNSAcquisition of CSi Palletising
24th Sep 202410:01 amRNSStandard form for notification of major holdings
18th Sep 20247:00 amRNSAcquisition of Boston Conveyor & Automation, Inc
10th Sep 20247:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.